CA2937471A1 - Formulation administrable oralement - Google Patents

Formulation administrable oralement Download PDF

Info

Publication number
CA2937471A1
CA2937471A1 CA2937471A CA2937471A CA2937471A1 CA 2937471 A1 CA2937471 A1 CA 2937471A1 CA 2937471 A CA2937471 A CA 2937471A CA 2937471 A CA2937471 A CA 2937471A CA 2937471 A1 CA2937471 A1 CA 2937471A1
Authority
CA
Canada
Prior art keywords
formulation
pharmaceutical agent
acid
chewing gum
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2937471A
Other languages
English (en)
Other versions
CA2937471C (fr
Inventor
Allen Greenspoon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA2937471A priority Critical patent/CA2937471C/fr
Priority to CA3028160A priority patent/CA3028160C/fr
Publication of CA2937471A1 publication Critical patent/CA2937471A1/fr
Application granted granted Critical
Publication of CA2937471C publication Critical patent/CA2937471C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Physiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
CA2937471A 2016-07-28 2016-07-28 Formulation administrable oralement Active CA2937471C (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CA2937471A CA2937471C (fr) 2016-07-28 2016-07-28 Formulation administrable oralement
CA3028160A CA3028160C (fr) 2016-07-28 2016-07-28 Formulation administrable oralement

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA2937471A CA2937471C (fr) 2016-07-28 2016-07-28 Formulation administrable oralement

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA3028160A Division CA3028160C (fr) 2016-07-28 2016-07-28 Formulation administrable oralement

Publications (2)

Publication Number Publication Date
CA2937471A1 true CA2937471A1 (fr) 2016-09-29
CA2937471C CA2937471C (fr) 2019-02-05

Family

ID=56998774

Family Applications (2)

Application Number Title Priority Date Filing Date
CA3028160A Active CA3028160C (fr) 2016-07-28 2016-07-28 Formulation administrable oralement
CA2937471A Active CA2937471C (fr) 2016-07-28 2016-07-28 Formulation administrable oralement

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CA3028160A Active CA3028160C (fr) 2016-07-28 2016-07-28 Formulation administrable oralement

Country Status (1)

Country Link
CA (2) CA3028160C (fr)

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018018152A1 (fr) * 2016-07-28 2018-02-01 Allen Greenspoon Nouvelle formulation par voie orale.
WO2020041860A1 (fr) * 2018-08-28 2020-03-05 Chirosyn Discovery Technologies Inc. Composition alcaline de cannabidiol
WO2020061687A1 (fr) * 2018-09-28 2020-04-02 Visceral Therapeutics Inc. Compositions pharmaceutiquement actives à base de cannabis et procédés d'utilisation pour traiter des affections gastro-intestinales
EP3528804A4 (fr) * 2016-10-20 2020-05-06 Axim Biotechnologies, Inc. Composition de gomme à mâcher comprenant des cannabinoïdes et des agonistes et/ou des antagonistes opioïdes
WO2020107114A1 (fr) * 2018-11-30 2020-06-04 Canopy Growth Corporation Formulations hydrosolubles de cannabinoïdes ou de composés dérivés du cannabis, leurs procédés de fabrication et leurs méthodes d'utilisation
US20200237662A1 (en) * 2019-01-25 2020-07-30 Medcan Pharma A/S Cannabinoid chewing gum with sugar alcohols
US10799450B2 (en) 2019-03-01 2020-10-13 Medcan Pharma A/S Tableted cannabinoid chewing gum with layered structure
US10933017B2 (en) 2019-03-01 2021-03-02 Nordiccan A/S Tableted cannabinoid chewing gum with polyvinyl acetate elastomer plasticizers
US11013685B2 (en) 2019-01-25 2021-05-25 Nordiccan A/S Cannabinoid chewing gum with improved release of cannabinoids
US11040932B2 (en) 2018-10-10 2021-06-22 Treehouse Biotech, Inc. Synthesis of cannabigerol
US11084770B2 (en) 2016-12-07 2021-08-10 Treehouse Biotech, Inc. Cannabis extracts
US11154496B2 (en) 2019-01-25 2021-10-26 Nordiccan A/S Cannabinoid chewing gum with polyvinyl acetate elastomer plasticizers
US11191720B2 (en) 2019-01-25 2021-12-07 Nordiccan A/S Chewing gum with improved delivery of cannabinoids
US11202771B2 (en) 2018-01-31 2021-12-21 Treehouse Biotech, Inc. Hemp powder
US11253473B2 (en) 2019-03-01 2022-02-22 Nordiccan A/S Method of producing tableted cannabinoid chewing gum
US11285184B2 (en) 2018-08-28 2022-03-29 Chirosyn Discovery Technologies Inc. Cannabidiol alkaline composition
US11406593B2 (en) 2019-01-25 2022-08-09 Nordiccan A/S Cannabinoid chewing gum with high intensity sweeteners
US11471405B2 (en) 2019-03-01 2022-10-18 Nordiccan A/S Tableted chewing gum with enhanced delivery of cannabinoids

Cited By (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018018152A1 (fr) * 2016-07-28 2018-02-01 Allen Greenspoon Nouvelle formulation par voie orale.
US10456357B2 (en) 2016-07-28 2019-10-29 Allen Greenspoon Orally administrable formulation
EP3528804A4 (fr) * 2016-10-20 2020-05-06 Axim Biotechnologies, Inc. Composition de gomme à mâcher comprenant des cannabinoïdes et des agonistes et/ou des antagonistes opioïdes
US11084770B2 (en) 2016-12-07 2021-08-10 Treehouse Biotech, Inc. Cannabis extracts
US11202771B2 (en) 2018-01-31 2021-12-21 Treehouse Biotech, Inc. Hemp powder
WO2020041860A1 (fr) * 2018-08-28 2020-03-05 Chirosyn Discovery Technologies Inc. Composition alcaline de cannabidiol
US11285184B2 (en) 2018-08-28 2022-03-29 Chirosyn Discovery Technologies Inc. Cannabidiol alkaline composition
WO2020061687A1 (fr) * 2018-09-28 2020-04-02 Visceral Therapeutics Inc. Compositions pharmaceutiquement actives à base de cannabis et procédés d'utilisation pour traiter des affections gastro-intestinales
US11040932B2 (en) 2018-10-10 2021-06-22 Treehouse Biotech, Inc. Synthesis of cannabigerol
WO2020107114A1 (fr) * 2018-11-30 2020-06-04 Canopy Growth Corporation Formulations hydrosolubles de cannabinoïdes ou de composés dérivés du cannabis, leurs procédés de fabrication et leurs méthodes d'utilisation
US11154496B2 (en) 2019-01-25 2021-10-26 Nordiccan A/S Cannabinoid chewing gum with polyvinyl acetate elastomer plasticizers
US11013685B2 (en) 2019-01-25 2021-05-25 Nordiccan A/S Cannabinoid chewing gum with improved release of cannabinoids
US11166910B2 (en) 2019-01-25 2021-11-09 Nordiccan A/S Cannabinoid chewing gum with sugar alcohols
US11191720B2 (en) 2019-01-25 2021-12-07 Nordiccan A/S Chewing gum with improved delivery of cannabinoids
US20200237662A1 (en) * 2019-01-25 2020-07-30 Medcan Pharma A/S Cannabinoid chewing gum with sugar alcohols
US20220016024A1 (en) * 2019-01-25 2022-01-20 Nordiccan A/S Cannabinoid chewing gum with sugar alcohols
US11406593B2 (en) 2019-01-25 2022-08-09 Nordiccan A/S Cannabinoid chewing gum with high intensity sweeteners
US11826463B2 (en) * 2019-01-25 2023-11-28 Nordiccan A/S Cannabinoid chewing gum with sugar alcohols
US10799450B2 (en) 2019-03-01 2020-10-13 Medcan Pharma A/S Tableted cannabinoid chewing gum with layered structure
US11253473B2 (en) 2019-03-01 2022-02-22 Nordiccan A/S Method of producing tableted cannabinoid chewing gum
US10933017B2 (en) 2019-03-01 2021-03-02 Nordiccan A/S Tableted cannabinoid chewing gum with polyvinyl acetate elastomer plasticizers
US11471405B2 (en) 2019-03-01 2022-10-18 Nordiccan A/S Tableted chewing gum with enhanced delivery of cannabinoids
US11833117B2 (en) 2019-03-01 2023-12-05 Nordiccan A/S Tableted cannabinoid chewing gum with layered structure

Also Published As

Publication number Publication date
CA2937471C (fr) 2019-02-05
CA3028160A1 (fr) 2016-09-29
CA3028160C (fr) 2021-03-30

Similar Documents

Publication Publication Date Title
AU2020257071B2 (en) Novel orally adminstrable formulation
CA2937471C (fr) Formulation administrable oralement
EP1648421B1 (fr) Films a dissolution orale
KR101074271B1 (ko) 불쾌한 맛을 효과적으로 은폐한 경구용 속용 필름
EP2821066B1 (fr) Film à haute teneur et à dissolution rapide à goût amer masqué comprenant du sildénafil comme principe actif
CN104271114B (zh) 含鸦片剂肠释放小珠的口腔膜剂
CN110621307A (zh) 含有烟碱的口香糖组合物
WO2009141321A2 (fr) Gommes à mâcher pouvant être conditionnées en comprimés
US8968770B2 (en) Multi-part kit comprising a chewing gum and further a flavor containing formulation
US20240156844A1 (en) Orally administrable formulation
KR101440808B1 (ko) 실데나필 또는 이의 약제학적으로 허용되는 염을 고함량으로 포함하는 속용필름